Grantham, Mayo, Van Otterloo & Co (GMO)’s Avantax, Inc. Common Stock AVTA Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTA
VBA
HPC
PCP
ECM
NM
SCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s AVTA Position: Q3 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Avantax, Inc. Common Stock (AVTA) in Q3 2022, closing a stake of 58,000 shares — an estimated $1.07M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AVTA in Q2 2017 and held it in 10 quarters. The position peaked at $1.67M in Q1 2022. 156 funds tracked by Wall St. Rank hold AVTA as of Q3 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Avantax, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 58,000 Avantax, Inc. Common Stock shares in Q3 2022, an estimated $1.07M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Avantax, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Avantax, Inc. Common Stock position peaked at $1.67M in Q1 2022.
- 156 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q3 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.